KENSING COMPLETES ACQUISITION OF HOPEWELL, VA AMPHOTERIC SURFACTANTS AND SPECIALTY ESTERS OPERATIONS FROM EVONIK CORPORATION.
Kensing, LLC, a leading manufacturer of natural vitamin E, plant sterols, specialty esters and high-purity anionic surfactants, and a portfolio company of One Rock Capital Partners, LLC (“One Rock”), today announced that it has successfully completed the previously announced acquisition of the Hopewell, Virginia amphoteric surfactants and specialty esters manufacturing operations from Evonik Corporation (“Evonik”).
“This transaction expands our existing surfactant and specialty esters product offerings and we’re pleased to officially welcome our colleagues at the Hopewell site into the Kensing family,” said Serge Rogasik, Chief Executive Officer of Kensing. “This transaction marks our second add-on acquisition since becoming a standalone company in June 2021. We look forward to building on this momentum by actively pursuing additional strategic opportunities aimed at providing our customers with an expanded range of high-quality, plant-based products and strengthening our leading position in our core markets.”
The amphoteric surfactants and specialty esters products acquired by Kensing in this transaction primarily serve the personal care market, focusing on skincare, hair care and oral care applications and are widely regarded in the industry as leaders in quality and reliability.
